PTG-300

Drug identity checked against registry records

Also recorded as Rusfertide

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)NCT04057040PTGXPhase 2Completed2023-02-14Actual
PTG-300 in Subjects With Hereditary HemochromatosisNCT04202965PTGXPhase 2Completed2021-10-06Actual
PTG-300 in Patients With Polycythemia Vera and Elevated HematocritNCT04767802PTGXPhase 2Completed2023-03-15Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.